Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.

Stainer, R; Matthews, S; Arshad, S H; McDonald, S; Robinson, J; Schapira, C; Foote, K D; Baird-Snell, M; Gregory, T; Pollock, I; Stevens, M T; Edwards, A M

Stainer, R; Matthews, S; Arshad, S H; McDonald, S; Robinson, J; Schapira, C; Foote, K D; Baird-Snell, M; Gregory, T; Pollock, I; Stevens, M T; Edwards, A M.

Affiliation

Stainer R; Synexus Limited, Crosby Clinical Research Centre, Burlington House, 3rd Floor, South Wing, Crosby Road North, Waterloo, Liverpool, UK.

Br J Dermatol ; 152(2): 334-41, 2005 Feb.

Article in En | MEDLINE | ID: mdl-15727648

Subject(s)

Cromolyn Sodium/therapeutic use; Dermatitis, Atopic/drug therapy; Dermatologic Agents/therapeutic use; Administration, Cutaneous; Child; Child, Preschool; Cromolyn Sodium/adverse effects; Dermatitis, Atopic/pathology; Dermatologic Agents/adverse effects; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids/administration & dosage; Humans; Male; Patient Satisfaction; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cromolyn Sodium / Dermatitis, Atopic / Dermatologic Agents Type of study: Clinical_trials Limits: Child / Child, preschool / Humans / Male Language: En Journal: Br J Dermatol Year: 2005 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links